Fri, Oct 24, 2014, 8:13 AM EDT - U.S. Markets open in 1 hr 17 mins


% | $
Quotes you view appear here for quick access.

Chelsea Therapeutics Internatio Message Board

  • followmeistowin followmeistowin Jul 17, 2013 9:46 AM Flag


    They must to prevent dangerous cash levels ....if not accepted they will be out of the raise

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I agree. Never underestimate how long it could take to get approval. They're down to 25 mil already? Not too long ago they were at 53 mil... so yeah, If we see 3.50, I'd say they might sell a little more to have some cash on hand for the sales ramp up, and maybe the next follow up study. They haven't seen 3.50 in a long while and any little thing could send CHTP tumbling to a buck again. I don't think they're in dire need of the cash, but if you have the chance to make your company safer by giving yourself a little margin, why not do it when times are good? 10 million shares gets them to about 76 million total shares, and nets them another 35 million dollars that they *might* need.

      Imagine if approval falls through though, I could see some very angry shareholders. Ouch. I'd be miffed.

    • they did not mention abut insufficient fund and need to raise cash ? where u see it at follo...etc?

    • Maybe a partner could step up, or buyout? One never knows, but the sector is hot and larger pharma needs pipeline products. Best to all CHTP longs.

      Sentiment: Strong Buy

    • Chelsea ended the quarter with $25.1 million in cash and cash equivalents compared to $28.4 million as of December 31, 2012. Chelsea anticipates that its cash and cash equivalents on hand at March 31 should fund the Company's operations into the third quarter of 2014. While details for a future clinical trial for Northera are yet to be determined, this projection assumes a new trial would commence dosing in the fourth quarter of 2013. In addition to the initial costs of a new trial, assumptions underlying this guidance cover costs related to the NDA re-submission. This current forecast does not include material activities related to an NDA approval or the commercialization of Northera.

6.520.00(0.00%)Jun 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.